NCT00091078: Oblimersen and Imatinib Mesylate in Treating Patients With Advanced Gastrointestinal Stromal Tumors That Cannot Be Removed By Surgery |
|
|
| Terminated | 2a | 96 | US | oblimersen sodium, augmerosen, G3139, G3139 bcl-2 antisense oligodeoxynucleotide, Genasense, imatinib mesylate, CGP 57148, Gleevec, Glivec, laboratory biomarker analysis | National Cancer Institute (NCI) | Gastrointestinal Stromal Tumor | 07/06 | | | |
